Manjula Mahendra Sangoi's Insider Trades & SAST Disclosures

Visit FAQs

Manjula Mahendra Sangoi's most recent trade in Aarti Pharmalabs Ltd. was a Acquisition of 7,500 Equity Shares done at an average price of Rs. 316.1 . Disclosure was reported to the exchange on Feb. 13, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

No reported SAST transactions available for Manjula Mahendra Sangoi in the Trendlyne database.

Add Superstar Alert
Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Aarti Pharmalabs
Manjula Mahendra Sangoi Directors Immediate Relative Acquisition 13 Feb 2023 7,500 15,000 (0.02%) 0.01% 316.1 2,370,784 09 Feb 2023
09 Feb 2023		 Insider Trading Equity Shares Market Purchase
Aarti Pharmalabs
Manjula Mahendra Sangoi Directors Immediate Relative Acquisition 13 Feb 2023 7,500 7,500 (0.01%) 0.01% 330.8 2,480,808 09 Feb 2023
09 Feb 2023		 Insider Trading Equity Shares Market Purchase
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST